54
|
Kunze D, Melzer I, Bennett D, Sanglard D, MacCallum D, Nörskau J, Coleman DC, Odds FC, Schäfer W, Hube B. Functional analysis of the phospholipase C gene CaPLC1 and two unusual phospholipase C genes, CaPLC2 and CaPLC3, of Candida albicans. MICROBIOLOGY-SGM 2005; 151:3381-3394. [PMID: 16207920 DOI: 10.1099/mic.0.28353-0] [Citation(s) in RCA: 31] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
Phospholipases C are known to be important regulators of cellular processes but may also act as virulence factors of pathogenic microbes. At least three genes in the genome of the human-pathogenic fungus Candida albicans encode phospholipases with conserved phospholipase C (Plc) motifs. None of the deduced protein sequences contain N-terminal signal peptides, suggesting that these phospholipases are not secreted. In contrast to its orthologue in Sacharomyces cerevisiae, CaPLC1 seems to be an essential gene. However, a conditional mutant with reduced transcript levels of CaPLC1 had phenotypes similar to Plc1p-deficient mutants in S. cerevisiae, including reduced growth on media causing increased osmotic stress, on media with a non-glucose carbon source, or at elevated or lower temperatures, suggesting that CaPlc1p, like the Plc1p counterpart in S. cerevisiae, may be involved in multiple cellular processes. Furthermore, phenotypic screening of the heterozygous DeltaCaplc1/CaPLC1 mutant showed additional defects in hyphal formation. The loss of CaPLC1 cannot be compensated by two additional PLC genes of C. albicans (CaPLC2 and CaPLC3) encoding two almost identical phospholipases C with no counterpart in S. cerevisiae but containing structural elements found in bacterial phospholipases C. Although the promoter sequences of CaPLC2 and CaPLC3 differed dramatically, the transcriptional pattern of both genes was similar. In contrast to CaPLC1, CaPLC2 and CaPLC3 are not essential. Although Caplc2/3 mutants had reduced abilities to produce hyphae on solid media, these mutants were as virulent as the wild-type in a model of systemic infection. These data suggest that C. albicans contains two different classes of phospholipases C which are involved in cellular processes but which have no specific functions in pathogenicity.
Collapse
Affiliation(s)
- Donika Kunze
- Robert Koch-Institut, Nordufer 20, D-13353, Berlin, Germany
| | - Inga Melzer
- Molecular Phytopathology and Genetics, University of Hamburg, Biocenter Klein Flottbek, Ohnhorststr. 18, D-22609 Hamburg, Germany
| | - Désirée Bennett
- Microbiology Research Division, School of Dental Science, University of Dublin, Trinity College, Dublin 2, Republic of Ireland
| | - Dominique Sanglard
- Institut de Microbiologie, Centre Hospitalier Universitaire Vaudois, CH-1011 Lausanne, Switzerland
| | - Donna MacCallum
- Aberdeen Fungal Group, School of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK
| | - Jan Nörskau
- Molecular Phytopathology and Genetics, University of Hamburg, Biocenter Klein Flottbek, Ohnhorststr. 18, D-22609 Hamburg, Germany
| | - David C Coleman
- Microbiology Research Division, School of Dental Science, University of Dublin, Trinity College, Dublin 2, Republic of Ireland
| | - Frank C Odds
- Aberdeen Fungal Group, School of Medical Sciences, University of Aberdeen, Aberdeen AB25 2ZD, UK
| | - Wilhelm Schäfer
- Molecular Phytopathology and Genetics, University of Hamburg, Biocenter Klein Flottbek, Ohnhorststr. 18, D-22609 Hamburg, Germany
| | - Bernhard Hube
- Robert Koch-Institut, Nordufer 20, D-13353, Berlin, Germany
| |
Collapse
|
58
|
Braun BR, van het Hoog M, d'Enfert C, Martchenko M, Dungan J, Kuo A, Inglis DO, Uhl MA, Hogues H, Berriman M, Lorenz M, Levitin A, Oberholzer U, Bachewich C, Harcus D, Marcil A, Dignard D, Iouk T, Zito R, Frangeul L, Tekaia F, Rutherford K, Wang E, Munro CA, Bates S, Gow NA, Hoyer LL, Köhler G, Morschhäuser J, Newport G, Znaidi S, Raymond M, Turcotte B, Sherlock G, Costanzo M, Ihmels J, Berman J, Sanglard D, Agabian N, Mitchell AP, Johnson AD, Whiteway M, Nantel A. A human-curated annotation of the Candida albicans genome. PLoS Genet 2005; 1:36-57. [PMID: 16103911 PMCID: PMC1183520 DOI: 10.1371/journal.pgen.0010001] [Citation(s) in RCA: 242] [Impact Index Per Article: 12.1] [Reference Citation Analysis] [Abstract] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/10/2005] [Accepted: 03/14/2005] [Indexed: 11/24/2022] Open
Abstract
Recent sequencing and assembly of the genome for the fungal pathogen Candida albicans used simple automated procedures for the identification of putative genes. We have reviewed the entire assembly, both by hand and with additional bioinformatic resources, to accurately map and describe 6,354 genes and to identify 246 genes whose original database entries contained sequencing errors (or possibly mutations) that affect their reading frame. Comparison with other fungal genomes permitted the identification of numerous fungus-specific genes that might be targeted for antifungal therapy. We also observed that, compared to other fungi, the protein-coding sequences in the C. albicans genome are especially rich in short sequence repeats. Finally, our improved annotation permitted a detailed analysis of several multigene families, and comparative genomic studies showed that C. albicans has a far greater catabolic range, encoding respiratory Complex 1, several novel oxidoreductases and ketone body degrading enzymes, malonyl-CoA and enoyl-CoA carriers, several novel amino acid degrading enzymes, a variety of secreted catabolic lipases and proteases, and numerous transporters to assimilate the resulting nutrients. The results of these efforts will ensure that the Candida research community has uniform and comprehensive genomic information for medical research as well as for future diagnostic and therapeutic applications.
Collapse
Affiliation(s)
- Burkhard R Braun
- Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America
| | - Marco van het Hoog
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - Christophe d'Enfert
- Unité Postulante Biologie et Pathogénicité Fongiques, INRA USC 2019, Institut Pasteur, Paris, France
| | - Mikhail Martchenko
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - Jan Dungan
- Department of Stomatology, University of California, San Francisco, California, United States of America
| | - Alan Kuo
- Department of Stomatology, University of California, San Francisco, California, United States of America
| | - Diane O Inglis
- Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America
| | - M. Andrew Uhl
- Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America
| | - Hervé Hogues
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | | | - Michael Lorenz
- Department of Microbiology and Molecular Genetics, Utah-Houston Medical School, Houston, Texas, United States of America
| | - Anastasia Levitin
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - Ursula Oberholzer
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - Catherine Bachewich
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - Doreen Harcus
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - Anne Marcil
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - Daniel Dignard
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - Tatiana Iouk
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - Rosa Zito
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - Lionel Frangeul
- Plate-Forme Intégration et Analyse Génomique, Institut Pasteur, Paris, France
| | - Fredj Tekaia
- Unité de Génétique Moléculaire des Levures, Institut Pasteur, Paris, France
| | | | - Edwin Wang
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - Carol A Munro
- School of Medical Sciences, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom
| | - Steve Bates
- School of Medical Sciences, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom
| | - Neil A Gow
- School of Medical Sciences, University of Aberdeen, Institute of Medical Sciences, Foresterhill, Aberdeen, United Kingdom
| | - Lois L Hoyer
- Department of Veterinary Pathobiology, University of Illinois at Urbana-Champaign, Urbana, Illinois, United States of America
| | - Gerwald Köhler
- Department of Stomatology, University of California, San Francisco, California, United States of America
| | - Joachim Morschhäuser
- Institut für Molekulare Infektionsbiologie, Universität Wurzburg, Wurzburg, Germany
| | - George Newport
- Department of Stomatology, University of California, San Francisco, California, United States of America
| | - Sadri Znaidi
- Institut de Recherches Cliniques de Montreal, Montreal, Quebec, Canada
| | - Martine Raymond
- Institut de Recherches Cliniques de Montreal, Montreal, Quebec, Canada
| | - Bernard Turcotte
- Department of Medicine, Royal Victoria Hospital, McGill University, Montreal, Quebec, Canada
| | - Gavin Sherlock
- Department of Genetics, Stanford University School of Medicine, Palo Alto, California, United States of America
| | - Maria Costanzo
- Department of Genetics, Stanford University School of Medicine, Palo Alto, California, United States of America
| | - Jan Ihmels
- Department of Molecular Genetics, Weizmann Institute of Science, Rehovot, Israel
| | - Judith Berman
- Department of Genetics, Cell Biology, and Development, University of Minnesota, Minneapolis, Minnesota, United States of America
| | - Dominique Sanglard
- Institute of Microbiology, University Hospital Lausanne, Lausanne, Switzerland
| | - Nina Agabian
- Department of Stomatology, University of California, San Francisco, California, United States of America
| | - Aaron P Mitchell
- Department of Microbiology and Institute of Cancer Research, Columbia University, New York, New York, United States of America
| | - Alexander D Johnson
- Department of Microbiology and Immunology, University of California, San Francisco, California, United States of America
| | - Malcolm Whiteway
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| | - André Nantel
- Biotechnology Research Institute, National Research Council Canada, Montreal, Quebec, Canada
| |
Collapse
|
59
|
Lee REB, Liu TT, Barker KS, Lee RE, Rogers PD. Genome-wide expression profiling of the response to ciclopirox olamine in Candida albicans. J Antimicrob Chemother 2005; 55:655-62. [PMID: 15814599 DOI: 10.1093/jac/dki105] [Citation(s) in RCA: 46] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023] Open
Abstract
OBJECTIVES The aim of this study was to identify changes in the gene expression profile of Candida albicans upon exposure to the hydroxypyridone anti-infective agent ciclopirox olamine in an effort to better understand its mechanism of action. METHODS C. albicans SC5314 was exposed to either medium alone or ciclopirox olamine at a concentration equivalent to the IC50 (0.24 mg/L) for 3 h. RNA was isolated and gene expression profiles were compared using DNA microarrays. Differential expression of select genes was confirmed by real-time reverse transcription (RT)-PCR. Mutants disrupted for CDR2 and both CDR1 and CDR2, as well as a clinical isolate overexpressing CDR1 and CDR2, were examined for changes in susceptibility to ciclopirox olamine. RESULTS A total of 49 genes were found to be responsive to ciclopirox olamine, including 36 up-regulated genes and 13 down-regulated genes. These included genes involved in small molecule transport (HGT11, HXT5, ENA22, PHO84, CDR4), iron uptake (FRE30, FET34, FTR1, FTR2, SIT1) and cell stress (SOD1, SOD22, CDR1, DDR48). Mutants disrupted for CDR2 and both CDR1 and CDR2, as well as a clinical isolate overexpressing CDR1 and CDR2, showed no change in susceptibility to ciclopirox olamine compared with the respective parent. CONCLUSIONS Consistent with the hypothesis that ciclopirox olamine acts as an iron chelator, it induced changes in expression of many genes involved in iron uptake. Despite induction of the multidrug efflux pump genes CDR1 and, to a lesser extent, CDR2 by ciclopirox olamine, these genes do not affect susceptibility to this agent.
Collapse
Affiliation(s)
- Robin E B Lee
- Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee Health Science Center, Memphis, TN 38163, USA
| | | | | | | | | |
Collapse
|